These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33069726)

  • 1. Autoantibodies to BPAG1e Trigger Experimental Bullous Pemphigoid in Mice.
    Makita E; Matsuzaki Y; Fukui T; Matsui A; Minakawa S; Nakano H; Ito K; Kijima H; Sawamura D
    J Invest Dermatol; 2021 May; 141(5):1167-1176.e3. PubMed ID: 33069726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BP230 autoantibodies in bullous pemphigoid.
    Shih YC; Wang B; Yuan H; Zheng J; Pan M
    J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
    Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
    J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
    Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
    J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230.
    Kiss M; Husz S; Jánossy T; Marczinovits I; Molnár J; Korom I; Dobozy A
    J Autoimmun; 2005 Feb; 24(1):1-10. PubMed ID: 15725571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
    Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor.
    Sawada K; Sawada T; Kobayashi T; Fujiki A; Matsushita T; Kawara S; Izumi K; Nishie W; Shimizu H; Takehara K; Hamaguchi Y
    Immunol Med; 2021 Mar; 44(1):53-55. PubMed ID: 32634333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for neutrophil elastase in experimental bullous pemphigoid.
    Liu Z; Shapiro SD; Zhou X; Twining SS; Senior RM; Giudice GJ; Fairley JA; Diaz LA
    J Clin Invest; 2000 Jan; 105(1):113-23. PubMed ID: 10619867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
    Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
    J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complement in experimental bullous pemphigoid.
    Liu Z; Giudice GJ; Swartz SJ; Fairley JA; Till GO; Troy JL; Diaz LA
    J Clin Invest; 1995 Apr; 95(4):1539-44. PubMed ID: 7706459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects on the pathogenesis of bullous pemphigoid].
    Schmidt E; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid: using animal models to study the immunopathology.
    Liu Z
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):41-6. PubMed ID: 14870984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.
    Clapé A; Muller C; Gatouillat G; Le Jan S; Barbe C; Pham BN; Antonicelli F; Bernard P
    Front Immunol; 2018; 9():479. PubMed ID: 29662486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease.
    Haeberle S; Wei X; Bieber K; Goletz S; Ludwig RJ; Schmidt E; Enk AH; Hadaschik EN
    J Allergy Clin Immunol; 2018 Dec; 142(6):1831-1842.e7. PubMed ID: 29704595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.